Werewolf Therapeutics Stock Forecast - Naive Prediction
| HOWL Stock | USD 0.70 0.10 16.67% |
The Naive Prediction forecasted value of Werewolf Therapeutics on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.07 and the sum of the absolute errors of 4.18. Werewolf Stock Forecast is based on your current time horizon. Although Werewolf Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Werewolf Therapeutics' systematic risk associated with finding meaningful patterns of Werewolf Therapeutics fundamentals over time.
As of now, the RSI of Werewolf Therapeutics' share price is approaching 37. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Werewolf Therapeutics, making its price go up or down. Momentum 37
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.41) | EPS Estimate Current Year (1.48) | EPS Estimate Next Year (1.25) | Wall Street Target Price 5.2 | EPS Estimate Current Quarter (0.38) |
Using Werewolf Therapeutics hype-based prediction, you can estimate the value of Werewolf Therapeutics from the perspective of Werewolf Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Werewolf Therapeutics using Werewolf Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Werewolf using crowd psychology based on the activity and movement of Werewolf Therapeutics' stock price.
Werewolf Therapeutics Short Interest
An investor who is long Werewolf Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Werewolf Therapeutics and may potentially protect profits, hedge Werewolf Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 1.1723 | Short Percent 0.0599 | Short Ratio 2.36 | Shares Short Prior Month 1.5 M | 50 Day MA 0.8286 |
Werewolf Therapeutics Hype to Price Pattern
Investor biases related to Werewolf Therapeutics' public news can be used to forecast risks associated with an investment in Werewolf. The trend in average sentiment can be used to explain how an investor holding Werewolf can time the market purely based on public headlines and social activities around Werewolf Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Werewolf Therapeutics Implied Volatility | 1.1 |
Werewolf Therapeutics' implied volatility exposes the market's sentiment of Werewolf Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Werewolf Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Werewolf Therapeutics stock will not fluctuate a lot when Werewolf Therapeutics' options are near their expiration.
The Naive Prediction forecasted value of Werewolf Therapeutics on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.07 and the sum of the absolute errors of 4.18. Werewolf Therapeutics after-hype prediction price | USD 0.7 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Werewolf Therapeutics to cross-verify your projections. Open Interest Against 2026-04-17 Werewolf Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Werewolf Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Werewolf Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Werewolf Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Werewolf Therapeutics' open interest, investors have to compare it to Werewolf Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Werewolf Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Werewolf. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Werewolf Therapeutics Additional Predictive Modules
Most predictive techniques to examine Werewolf price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Werewolf using various technical indicators. When you analyze Werewolf charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Werewolf Therapeutics Cash Forecast
To forecast cash or other financial indicators, analysts must employ diverse statistical methods, techniques, and algorithms. This approach allows them to detect underlying patterns in the Werewolf Therapeutics' financial statements, predicting their influence on future market prices.
Cash | First Reported 2020-03-31 | Previous Quarter 77.6 M | Current Value 65.7 M | Quarterly Volatility 38.5 M |
Werewolf Therapeutics Naive Prediction Price Forecast For the 24th of January
Given 90 days horizon, the Naive Prediction forecasted value of Werewolf Therapeutics on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.07, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.18.Please note that although there have been many attempts to predict Werewolf Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Werewolf Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Werewolf Therapeutics Stock Forecast Pattern
| Backtest Werewolf Therapeutics | Werewolf Therapeutics Price Prediction | Buy or Sell Advice |
Werewolf Therapeutics Forecasted Value
In the context of forecasting Werewolf Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Werewolf Therapeutics' downside and upside margins for the forecasting period are 0.01 and 8.23, respectively. We have considered Werewolf Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Werewolf Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Werewolf Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.9944 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0674 |
| MAPE | Mean absolute percentage error | 0.0805 |
| SAE | Sum of the absolute errors | 4.1807 |
Predictive Modules for Werewolf Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Werewolf Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Werewolf Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Werewolf Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Werewolf Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Werewolf Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Werewolf Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Werewolf Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Werewolf Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Werewolf Therapeutics' historical news coverage. Werewolf Therapeutics' after-hype downside and upside margins for the prediction period are 0.03 and 8.06, respectively. We have considered Werewolf Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Werewolf Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Werewolf Therapeutics is based on 3 months time horizon.
Werewolf Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Werewolf Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Werewolf Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Werewolf Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.14 | 7.41 | 0.02 | 10.67 | 12 Events / Month | 5 Events / Month | In about 12 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.70 | 0.70 | 0.00 |
|
Werewolf Therapeutics Hype Timeline
Werewolf Therapeutics is currently traded for 0.70. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of -10.67. Werewolf is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -1.14%. %. The volatility of related hype on Werewolf Therapeutics is about 79.16%, with the expected price after the next announcement by competition of -9.97. About 42.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.98. Some equities with similar Price to Book (P/B) outperform the market in the long run. Werewolf Therapeutics recorded a loss per share of 1.62. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 12 days. Check out Historical Fundamental Analysis of Werewolf Therapeutics to cross-verify your projections.Werewolf Therapeutics Related Hype Analysis
Having access to credible news sources related to Werewolf Therapeutics' direct competition is more important than ever and may enhance your ability to predict Werewolf Therapeutics' future price movements. Getting to know how Werewolf Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Werewolf Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IOBT | IO Biotech | 0.20 | 16 per month | 11.88 | 0.05 | 24.24 | (14.53) | 85.37 | |
| SPRB | Spruce Biosciences Common | (78.02) | 14 per month | 0.00 | (0.13) | 10.15 | (9.96) | 31.24 | |
| OTLK | OUTLOOK THERAPEUTICS INC | 0.04 | 10 per month | 0.00 | (0.09) | 12.74 | (11.11) | 73.07 | |
| ACET | Adicet Bio | (7.18) | 16 per month | 0.00 | (0.25) | 6.18 | (7.60) | 16.66 | |
| NRXP | NRX Pharmaceuticals | 0.33 | 14 per month | 0.00 | (0.1) | 7.34 | (8.02) | 21.29 | |
| LITS | Lite Strategy | (0.05) | 6 per month | 0.00 | (0.08) | 7.73 | (9.52) | 26.34 | |
| OSTX | OS Therapies Incorporated | (0.02) | 10 per month | 0.00 | (0.1) | 5.49 | (6.84) | 16.39 | |
| CUE | Cue Biopharma | 0.45 | 23 per month | 0.00 | (0.12) | 11.11 | (12.50) | 50.98 | |
| INMB | INmune Bio | 0.00 | 0 per month | 0.00 | (0.04) | 6.81 | (7.51) | 21.68 |
Other Forecasting Options for Werewolf Therapeutics
For every potential investor in Werewolf, whether a beginner or expert, Werewolf Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Werewolf Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Werewolf. Basic forecasting techniques help filter out the noise by identifying Werewolf Therapeutics' price trends.Werewolf Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Werewolf Therapeutics stock to make a market-neutral strategy. Peer analysis of Werewolf Therapeutics could also be used in its relative valuation, which is a method of valuing Werewolf Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Werewolf Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Werewolf Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Werewolf Therapeutics shares will generate the highest return on investment. By undertsting and applying Werewolf Therapeutics stock market strength indicators, traders can identify Werewolf Therapeutics entry and exit signals to maximize returns.
Werewolf Therapeutics Risk Indicators
The analysis of Werewolf Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Werewolf Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting werewolf stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.59 | |||
| Standard Deviation | 7.28 | |||
| Variance | 53.01 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Werewolf Therapeutics
The number of cover stories for Werewolf Therapeutics depends on current market conditions and Werewolf Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Werewolf Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Werewolf Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Werewolf Therapeutics Short Properties
Werewolf Therapeutics' future price predictability will typically decrease when Werewolf Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Werewolf Therapeutics often depends not only on the future outlook of the potential Werewolf Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Werewolf Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 43.9 M | |
| Cash And Short Term Investments | 111 M |
Check out Historical Fundamental Analysis of Werewolf Therapeutics to cross-verify your projections. For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Werewolf Therapeutics. If investors know Werewolf will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Werewolf Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Werewolf Therapeutics is measured differently than its book value, which is the value of Werewolf that is recorded on the company's balance sheet. Investors also form their own opinion of Werewolf Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Werewolf Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Werewolf Therapeutics' market value can be influenced by many factors that don't directly affect Werewolf Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Werewolf Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Werewolf Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Werewolf Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.